Results 61 to 70 of about 8,006 (148)

Legendre sums, Soto–Andrade sums and Kloosterman sums [PDF]

open access: yesPacific Journal of Mathematics, 2002
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +1 more source

The Exotic Inverted Kloosterman Sum

open access: yesInternational Mathematics Research Notices
Abstract Let $B$ be a product of finitely many finite fields containing $\mathbb{F}_{q}$, $\psi :\mathbb{F}_{q}\to \overline{\mathbb{Q}}_\ell ^{*}$ a nontrivial additive character, and $\chi : B^{*}\to \overline{\mathbb{Q}}_\ell ^{*}$ a multiplicative character.
Fu, Lei, Wan, Daqing
openaire   +3 more sources

On the distribution of angles of Kloosterman sums.

open access: yesJournal für die reine und angewandte Mathematik (Crelles Journal), 1989
Let \({\mathbb{F}}_ q\) denote the finite field with q elements where q is a prime power. For \(\lambda \in {\mathbb{F}}_ q^{\times}\) let \(\theta\) (q,\(\lambda)\) be the unique angle defined by a certain Kloosterman sum. In this paper the author applies results due to \textit{P. Deligne} [Publ. Math., Inst. Hautes Étud. Sci.
openaire   +2 more sources

On the moments of Kloosterman sums and fibre products of Kloosterman curves

open access: yesFinite Fields and Their Applications, 2008
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire   +1 more source

Distress in parents of children with first-onset steroid-sensitive nephrotic syndrome. [PDF]

open access: yesPediatr Nephrol, 2023
Veltkamp F   +6 more
europepmc   +1 more source

Health-related quality of life of children with first onset steroid-sensitive nephrotic syndrome. [PDF]

open access: yesEur J Pediatr, 2023
Veltkamp F   +7 more
europepmc   +1 more source

Matrix Kloosterman sums

open access: yesAlgebra & Number Theory
57 pages, some minor changes done and new references ...
Erdélyi, Márton, Tóth, Árpád
openaire   +3 more sources

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer. [PDF]

open access: yesCancers (Basel), 2022
de Witte CJ   +12 more
europepmc   +1 more source

Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer. [PDF]

open access: yesPharmaceutics, 2022
Oosting LT   +9 more
europepmc   +1 more source

An identity for the Kloosterman sum

open access: yes, 2010
We establish a simple identity and using it we find a new proof of a result of Kloosterman.
openaire   +2 more sources

Home - About - Disclaimer - Privacy